This site is moving on 12/18/18 and will not be available as of the morning of the Dec 18.
If you did not receive an email inviting you to the new site click the link below and you will be prompted to request access.
The Pacific Cancer Research Consortium (PCRC) is a Community site in the NCI Community Oncology Research Program (NCORP). NCORP is a national network of investigators, cancer care providers, academic institutions, and other organizations. The overall goal of NCORP is to bring cancer clinical trials (cancer control, prevention, screening, treatment, and imaging), as well as cancer care delivery research (CCDR), to individuals in their own communities, thus generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
PCRC is composed of three primary components (the grant holder and its co-leading institutions), their sub-components, and 27 other participating components from 5 different states (Alaska, Washington, Oregon, Idaho, and California). Altogether, the PCRC-NCORP is a consortium of 48 sites.
The three primary components are: Swedish Cancer Institute (SCI), NCORP grant holder and based in Seattle, WA; St. Luke's Mountain States Tumor Institute (MSTI), based in Boise, ID; and Providence Portland Medical Center (PPMC), based in Portland, OR. Swedish Cancer Institute and Providence Portland Medical Center both belong to the Providence Health & Services (PH&S) health care system based in Renton Washington.
The leadership structure for PCRC includes three Principal Investigators (PI). Gary Goodman, MD (SCI) is the Contact PI for PCRC, and Alison Conlin, MD (PPMC) and Benjamin Bridges, MD (MSTI) are the other two co-PIs.